| 2017 | First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials | Wasan, Harpreet S.; GRACE PEN-HSIU CHAO; Sharma, Navesh K.; Taieb, Julien; Heinemann, Volker; Ricke, Jens; Peeters, Marc; Findlay, Michael; Weaver, Andrew; Mills, Jamie; Wilson, Charles; ADRIAN RAUCHFLEISCH; Francis, Anne; Moschandreas, Joanna; Virdee, Pradeep S.; Dutton, Peter; Love, Sharon; Gebski, Val; Gray, Alastair; Bateman, Andrew; Blesing, Claire; BEI-EN CHANG; Chau, Ian; Cummins, Sebastian; Cunningham, David; Falk, Stephen; Hadaki, Maher; Hall, Marcia; Hickish, Tamas; Hornbuckle, Joanne; Lofts, Fiona; Lowndes, Sarah; Mayer, Astrid; Metcalfe, Matthew; Middleton, Gary; Montazeri, Amir; Muirhead, Rebecca; Polychronis, Andreas; Purcell, Colin; RICHARD PING CHENG; Sharma, Ricky A.; Sherwin, Liz; Smith, David; Soomal, Rubin; Swinson, Daniel; Walther, Axel; Wilson, Greg; Amin, Pradip; AN-BANG WANG; Balosso, Jacques; Beny, Alex; Bloomgarden D.; BEI-EN CHANG; Bruch, Harald Robert; Bui, James; Burge, Matthew; Cardaci, Giuseppe; Carlisle, James; Chai, Seungjean; Chen, Yi Jen; Chevallier, Patrick; Chuong, Michael; Clarke, Stephen; Coveler, Andrew; Craninx, Michael; Delanoit, Thierry; Deleporte A.; Eliadis, Paul; Facchini, Francis; Ferguson, Thomas; Ferrante, Michel; Frenette, Gary; Frick, Jacob; Ganju, Vinod; Garofalo, Michael; KAI-PING GRACE YAO; Gehbauer, Gerald; George, Benjamin; Geva, Ravit; Gordon, Michael; KAI-PING GRACE YAO; Gulec, Seza; Hannigan, James; van Hazel, Guy; Heching, Norman; Helmberger, Thomas; Hendlisz, Alain; Hendrickx, Koen; Holtzman, Matthew; I-RUE LAI; Jackson, Christopher; James, Philip; KATHERINE ANN KIM; Karapetis, Chris; KATHERINE ANN KIM; Ko, Yon Dschun; Kr?ning, Hendrik; Lammert, Frank; Liauw, Winston; JIN-TUNG LIANG; Louafi S.; de Man M.; Margolis J.; Martin R.; Martoni A.; Marx G.; Matos M.; Monsaert E.; Moons V.; Nott L.; Nusch A.; O'Donnell A.; Ozer H.; Padia S.; Pavlakis N.; Perez D.; Pluntke S.; Polus M.; Powell A.; Pracht M.; Price T.; Ransom D.; Rebischung C.; Ridwelski K.; Riera-Knorrenschild J.; Riess H.; Rilling W.; Robinson B.; Rodr?guez J.; Sanchez F.; Sauerbruch T.; Savin M.; Scheidhauer K.; Schneiderman E.; Seeger G.; Segelov E.; Schmueli E.S.; Shani A.; Shannon J.; Shibata S.; Singhal N.; Smith D.; Smith R.; Stemmer S.; St?tzer O.; Strickland A.; Tatsch K.; Terrebonne E.; Tichler T.; Vehling-Kaiser U.; Vera-Garcia R.; Vogl T.; Walpole E.; Wang E.; Whiting S.; Wolf I.; Ades S.; Aghmesheh M.; Auber M.; Ayala H.; Boland P.; Bouche E.; Bowers C.; Bremer C.; Casado A.R.; Cooray P.; Crain M.; De Wit M.; Dowling K.; Durand A.; Faivre S.; Feeney K.; Ferru A.; Fragoso M.; Granetto C.; Hammel P.; Issacs R.; Iyer R.; Kim Y.H.; JIN-TUNG LIANG ; Lim L.; Liu J.H.; Masi G.; Mosconi S.; Numico G.; Ratner L.; Sae-Won H.; Singh M.; Stoltzfus P.; Tan I.; Trogu A.; Underhill C.; Westcott M.; FOXFIRE trial investigators, SIRFLOX trial investigators, FOXFIRE-Global trial investigators, SIRFLOX trial investigators, FOXFIRE-Global trial investigators, FOXFIRE-Global trial investigators | The Lancet Oncology | 243 | 217 | |
